P53 IS COVALENTLY LINKED TO 5.8S RIBOSOMAL-RNA

被引:98
作者
FONTOURA, BMA
SOROKINA, EA
DAVID, E
CARROLL, RB
机构
[1] NYU, SCH MED, DEPT PATHOL, 550 1ST AVE, NEW YORK, NY 10016 USA
[2] NYU, SCH MED, KAPLAN CANC CTR, NEW YORK, NY 10016 USA
关键词
D O I
10.1128/MCB.12.11.5145
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the isolation and identification of the RNA specifically immunoprecipitated and covalently linked to the tumor suppressor gene product p53. After treatment with proteinase K, the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) band of p53 yields a single, discrete 157-nucleotide RNA, which was cloned, sequenced, and identified as 5.8S rRNA. 5.8S rRNA was obtained only after proteolysis of the p53 SDS-PAGE band. Free 5.8S rRNA did not comigrate with p53 in SDS-PAGE. This RNA was only immunoprecipitated from cells containing p53. Protein-free RNA obtained by proteolysis of the p53 band hybridized to the single-stranded DNA vector containing the antisense sequence of 5.8S rRNA. The covalence of the p53-5.8S rRNA linkage was demonstrated by the following findings: (i) p53 and the linked 5.8S rRNA comigrated in SDS-PAGE; (ii) only after treatment of the p53-RNA complex with proteinase K did the 5.8S rRNA migrate differently from p53-linked 5.8S rRNA; and (iii) this isolated RNA was found linked to phosphoserine, presumably at the 5' end. Covalent linkage to the single, specific RNA suggests that p53 may be involved in regulating the expression or function of 5.8S rRNA.
引用
收藏
页码:5145 / 5151
页数:7
相关论文
共 41 条
  • [1] WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION
    BARGONETTI, J
    FRIEDMAN, PN
    KERN, SE
    VOGELSTEIN, B
    PRIVES, C
    [J]. CELL, 1991, 65 (06) : 1083 - 1091
  • [2] A SIMPLE METHOD FOR CLONING BLUNT ENDED DNA FRAGMENTS
    BHAT, GJ
    LODES, MJ
    MYLER, PJ
    STUART, KD
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (02) : 398 - 398
  • [3] CHALLBERG MP, 1990, P NATL ACAD SCI USA, V77, P5105
  • [4] CHAMPOUX JJ, 1981, J BIOL CHEM, V256, P4805
  • [5] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767
  • [6] WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO
    FARMER, G
    BARGONETTI, J
    ZHU, H
    FRIEDMAN, P
    PRYWES, R
    PRIVES, C
    [J]. NATURE, 1992, 358 (6381) : 83 - 86
  • [7] PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN
    FIELDS, S
    JANG, SK
    [J]. SCIENCE, 1990, 249 (4972) : 1046 - 1049
  • [8] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093
  • [9] COVALENT LINKAGE OF A PROTEIN TO A DEFINED NUCLEOTIDE-SEQUENCE AT 5'-TERMINUS OF VIRION AND REPLICATIVE INTERMEDIATE RNAS OF POLIOVIRUS
    FLANEGAN, JB
    PETTERSSON, RF
    AMBROS, V
    HEWLETT, MJ
    BALTIMORE, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (03) : 961 - 965
  • [10] ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM
    GANNON, JV
    GREAVES, R
    IGGO, R
    LANE, DP
    [J]. EMBO JOURNAL, 1990, 9 (05) : 1595 - 1602